Alpers-Huttenlocher syndrome.
Saneto RP, Cohen BH, Copeland WC, Naviaux RK.
Pediatr Neurol. 2013 Mar;48(3):167-78. doi: 10.1016/j.pediatrneurol.2012.09.014.
Astrocytic pathology in Alpers' syndrome.
Smith LA, Chen C, Lax NZ, Taylor RW, Erskine D, McFarland R.
Acta Neuropathol Commun. 2023 May 31;11(1):86. doi: 10.1186/s40478-023-01579-w.
Alpers-huttenlocher syndrome: origins of clinicopathologic recognition.
Rust RS.
Pediatr Neurol. 2013 Mar;48(3):165-6. doi: 10.1016/j.pediatrneurol.2013.01.004.
Alpers syndrome: progressive neuronal degeneration of children with liver disease.
Gordon N.
Dev Med Child Neurol. 2006 Dec;48(12):1001-3. doi: 10.1017/S0012162206002209.
Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome.
Smith LA, Erskine D, Blain A, Taylor RW, McFarland R, Lax NZ.
Neuropathol Appl Neurobiol. 2022 Oct;48(6):e12833. doi: 10.1111/nan.12833. Epub 2022 Jul 19.
Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study.
Hayhurst H, Anagnostou ME, Bogle HJ, Grady JP, Taylor RW, Bindoff LA, McFarland R, Turnbull DM, Lax NZ.
Brain Pathol. 2019 Jan;29(1):97-113. doi: 10.1111/bpa.12640. Epub 2018 Oct 9.
[Alpers' syndrome].
Nakamura M.
Nihon Rinsho. 2002 Apr;60 Suppl 4:402-5.
Molecular diagnosis of Alpers syndrome.
Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK.
J Hepatol. 2006 Jul;45(1):108-16. doi: 10.1016/j.jhep.2005.12.026. Epub 2006 Feb 20.
Specific EEG markers in POLG1 Alpers' syndrome.
van Westrhenen A, Cats EA, van den Munckhof B, van der Salm SMA, Teunissen NW, Ferrier CH, Leijten FSS, Geleijns KPW.
Clin Neurophysiol. 2018 Oct;129(10):2127-2131. doi: 10.1016/j.clinph.2018.07.016. Epub 2018 Aug 4.
Alpers syndrome with mutations in POLG: clinical and investigative features.
Hunter MF, Peters H, Salemi R, Thorburn D, Mackay MT.
Pediatr Neurol. 2011 Nov;45(5):311-8. doi: 10.1016/j.pediatrneurol.2011.07.008.
